MetLife Small Company Equity FundMSVVX
Type
Mutual fund
Peer group
US equity: mid companies
Net assets
$7.0M
Expense ratio
1.24%
1-year return
+10.1%
3 years, a year
+8.4%
5 years, a year
+6.4%
Holdings
77
What it aims to do.
The MetLife Small Company Equity Fund (the Small Company Equity Fund or the Fund) seeks to provide long-term capital appreciation with less volatility than the U.S. small company market.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| N/A | 4.79% |
| AXSM Axsome Therapeutics, Inc. | 1.93% |
| KTB Kontoor Brands, Inc. | 1.89% |
| Advanced Energy Industries, Inc. | 1.81% |
| LFUS Littelfuse, Inc. | 1.79% |
| NWN Northwest Natural Holding Company | 1.75% |
| PLXS Plexus Corp. | 1.73% |
| SPDR Series Trust - SPDR S&P Biotech ETF | 1.71% |
| PRAX Praxis Precision Medicines Inc | 1.70% |
| iShares Russell 2000 ETF | 1.60% |
More on MSVVX.
- MSVVX overview
- MSVVX holdings
- MSVVX risk
- MSVVX costs
- MSVVX money in and out
- MSVVX share classes
- Compare MSVVX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.